Navigation Links
DuPont Chair & CEO: Delivering Innovative Solutions and Long-term Growth
Date:6/7/2011

NEW YORK, June 7, 2011 /PRNewswire/ -- DuPont (NYSE: DD) Chair and CEO Ellen Kullman told investors at the JPMorgan Diversified Industries Conference to expect attractive long-term growth from DuPont through product and process innovation, selective investment in attractive areas, broad-based growth, especially in developing markets, and a relentless focus on productivity.  Kullman also reaffirmed DuPont's 2011 earnings per share (EPS) outlook in the range of $3.65 to $3.85 per share, excluding the impact of Danisco.  As previously announced, the Danisco acquisition could reduce 2011 earnings by $.30-$.45 per share on a reported basis.

"We believe DuPont is uniquely positioned to tackle big global challenges that offer the opportunity for significant top-line growth and value creation," said Kullman.  "The recent acquisition of Danisco is a perfect fit with our growth strategy around feeding a growing population, decreasing dependence on fossil fuels and protecting people and the environment.  

"We will leverage Danisco's world-leading capabilities in enzymes and fermentation, with DuPont's strengths in biomass processing and microbial engineering.  This combination results in a powerful, integrated set of tools to create the next generation of cost-effective biofuels and biobased materials," said Kullman. "Simply put, our vision is to start with renewable raw materials and create differentiated products with excellent environmental profiles and superior economics for our customers."

Kullman indicated that DuPont continues to focus on market-driven science to meet market needs.  In 2010, 31 percent of the company's sales came from products that were introduced within the past 4 years, "We have made innovation and productivity a part of our DNA at DuPont,"
'/>"/>

SOURCE DuPont
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. DuPont Obtains Biotechnology Endorsement for Pioneer(R) Brand Products
2. Robert L. Brent, MD, PhD, Honored with 2008 Alfred I. duPont Award for Excellence in Childrens Health Care
3. DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels
4. DuPont and State of Delaware Unveil $80 Million Innovation Center Partnership
5. DuPont Expands Seed Production Capacity to Meet Growing Demand for Seed, Grain
6. DuPont Opens Research & Development Center in India
7. DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale-Up for New Bio-based Product
8. DuPont Launches Innovative Renewably Sourced Material for Carpet Cushion
9. DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow
10. DuPont Unveils New Strategy to Expand its Seed Business
11. DuPont Acquires Ag Data Management Business to Enhance Information Solutions for Growers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... -- Research and Markets ( ... "Analysis of the Global Flow Cytometry Market ... Globally, flow cytometry remains a popular tool for ... stem cells. But the market is witnessing active ... from underdeveloped nations to quantitate CD4 cell markers ...
(Date:7/28/2015)... ... ... VetStem Biopharma will be offering weekly private guided tours of our new ... The tour and course will be given every Wednesday at 6pm to local interested ... members are welcome to attend with their veterinarian as well. Participants will be able ...
(Date:7/28/2015)... 2015 Tauriga Sciences, Inc. (OTCQB:  TAUG) or ... today announced that its stockholders approved an increase in ... the Company from 1,000,000,000 to 2,500,000,000 at its Special ... the Law Offices of Nixon Peabody LLP in Midtown ... were 480,655,929 shares of common stock represented either by ...
(Date:7/28/2015)... 2015  Moerae Matrix Inc. announced today the ... with MMI-0100, a first-in-class inhibitor of MAPKAP kinase ... disorders characterized by inflammation and fibrosis.  The study, ... , is a double-blind, two-way cross-over design lipopolysaccharide ... tolerability of MMI-0100 when given via inhalation to ...
Breaking Biology Technology:Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2
... CARLSBAD, Calif., Feb. 12 Ardea Biosciences,Inc. (Nasdaq: RDEA ... of Ardea Biosciences, will present at the Roth Capital Partners,20th ... February 19, 2008 Time: 4:00 p.m. Pacific Time ... CA Webcast: http://www.wsw.com/webcast/roth16/rdea/ or ...
... Meeting Date Also Announced, SILVER SPRING, Md., ... ) announced today that it will,release its 2007 ... of market on Tuesday, February 19, 2008., ... Tuesday,February 19, 2008, at 9:00 a.m. Eastern Time. ...
... ConBio Lasers to be Exclusively Featured in Leading Dental Education ... ... 12 HOYA ConBio(TM), a global,leader in dental and aesthetic ... internationally recognized dental education,company, in which VersaWave(TM) and DioDent(TM) Micro ...
Cached Biology Technology:Ardea Biosciences to Present at Roth Capital Partners' 20th Annual OC Growth Stock Conference 2HOYA ConBio and The Hornbrook Group Announce Expanded Alliance 2HOYA ConBio and The Hornbrook Group Announce Expanded Alliance 3
(Date:7/2/2015)... 25, 2015 Research ... of the "Natural Language Processing Market by ... OCR, Pattern & Image Recognition) - Worldwide Forecast ... The key vendors occupying the market are ... Microsoft Corporation, NetBase Solutions, SAS Institute Inc., Verint ...
(Date:6/29/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ) ... Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... America Biomedical Sensors market is estimated at $0.65 billion ... period 2014-2020 The near future will bring ... of each individual. These sensors can be set to ...
(Date:6/24/2015)... , June 24, 2015 The biologics ... The major drivers for the market include growth of ... of new drug launches. Over the years, the number ... Between 2001 and 2010, the FDA approved 225 drug ... to WIPO, Europe accounted for ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
... a DNA-based "biomarker" blood test as a complement to ... men for prostate cancer. University of Cincinnati (UC) researchers ... British Journal of Cancer . Researchers conducted ... methylation in bodily fluids. The goal was to evaluate ...
... roles of microRNAs is announced today in Nature ... to tools to investigate the biological role and significance ... is a "library" of mutant mouse embryonic stem (ES) ... genes, have been deleted. Using these tools researchers can ...
... 2011) The human genome is peppered with repeated ... thousands of consecutive copies of the same sequence. During ... place the genome at risk for dangerous rearrangements from ... repetitive DNA, in part because much of it is ...
Cached Biology News:Cancer biomarker -- detectable by blood test -- could improve prostate cancer detection 2New resource to unlock the role of microRNAs 2New resource to unlock the role of microRNAs 3How yeast chromosomes avoid the bad breaks 2How yeast chromosomes avoid the bad breaks 3